Daily SignalsNeutral
2696 companies scored · 2026-10-15 run in progress: 5121 of ~5380 signals so far · Alpha · vs marketSwitch to Total · 30D 90D
Distribution of the day's forecasts
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
63 companies
Sorted by 90D forecast ↓
| Ticker | Rating | 90D | Δ |
|---|---|---|---|
| CYPHCYPHERPUNK TECHNOLOGIES INC. | +0.24% | · | |
| PGENPRECIGEN, INC. | +0.24% | ▼ 2 | |
| MISTMilestone Pharmaceuticals Inc. | +0.22% | ▼ 1 | |
| HALOHALOZYME THERAPEUTICS, INC. | +0.21% | ▼ 1 | |
| ANABANAPTYSBIO, INC | +0.19% | · | |
| AMRNAMARIN CORP PLC\UK | +0.17% | · | |
| GMABGENMAB A/S | +0.17% | · | |
| ACBAURORA CANNABIS INC | +0.16% | · | |
| SIGASIGA TECHNOLOGIES INC | +0.16% | · | |
| MOLNMOLECULAR PARTNERS AG | +0.14% | · | |
| ALNYALNYLAM PHARMACEUTICALS, INC. | +0.12% | ▲ 1 | |
| SMMTSummit Therapeutics Inc. | +0.11% | · | |
| HCMHUTCHMED (China) Ltd | +0.10% | · | |
| KROSKeros Therapeutics, Inc. | +0.10% | ▼ 2 | |
| LXRXLEXICON PHARMACEUTICALS, INC. | +0.07% | ▼ 1 | |
| SPRYARS Pharmaceuticals, Inc. | +0.06% | · | |
| ENGNenGene Therapeutics Inc. | +0.04% | ▼ 2 | |
| INSMINSMED Inc | +0.03% | · | |
| SABSSAB Biotherapeutics, Inc. | +0.02% | · | |
| RGENREPLIGEN CORP | +0.01% | ▼ 1 | |
| BBIOBridgeBio Pharma, Inc. | -0.04% | · | |
| CLLSCellectis S.A. | -0.04% | · | |
| XTLBXTL BIOPHARMACEUTICALS LTD | -0.05% | new | |
| QGENQIAGEN N.V. | -0.07% | ▲ 1 | |
| AGIOAGIOS PHARMACEUTICALS, INC. | -0.10% | · | |
| BHCBausch Health Companies Inc. | -0.10% | · | |
| VTRSViatris Inc | -0.13% | · | |
| AUTLAutolus Therapeutics plc | -0.14% | ▼ 2 | |
| COGTCogent Biosciences, Inc. | -0.14% | ▲ 1 | |
| CYRXCryoport, Inc. | -0.16% | ▼ 1 | |
| NRIXNurix Therapeutics, Inc. | -0.18% | · | |
| MRKMerck & Co., Inc. | -0.19% | ▲ 1 | |
| CGENCOMPUGEN LTD | -0.22% | · | |
| FTHFaeth Therapeutics, Inc. | -0.24% | ▼ 2 | |
| GALTGALECTIN THERAPEUTICS INC | -0.26% | · | |
| RIGLRIGEL PHARMACEUTICALS INC | -0.26% | ▼ 2 | |
| NWBONORTHWEST BIOTHERAPEUTICS INC | -0.32% | · | |
| INVAInnoviva, Inc. | -0.41% | ▲ 1 | |
| BMRNBIOMARIN PHARMACEUTICAL INC | -0.47% | ▲ 1 | |
| ABBVAbbVie Inc. | -0.48% | ▲ 2 | |
| LLYELI LILLY & Co | -0.48% | ▼ 1 | |
| PCRXPacira BioSciences, Inc. | -0.51% | · | |
| KRYSKrystal Biotech, Inc. | -0.54% | ▼ 1 | |
| ARDXARDELYX, INC. | -0.55% | ▼ 2 | |
| LEGNLegend Biotech Corp | -0.55% | · | |
| LKFTLakefront Biotherapeutics NV | -0.55% | ▲ 1 | |
| REGNREGENERON PHARMACEUTICALS, INC. | -0.57% | · | |
| DBVTDBV Technologies S.A. | -0.62% | ▲ 1 | |
| AMPHAmphastar Pharmaceuticals, Inc. | -0.63% | · | |
| BMYBRISTOL MYERS SQUIBB CO | -0.63% | ▲ 2 |
By sector
Median 90D forecast per sector. Click to filter.
Rating changes
Unlock the full ranking
Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.
See plans Create a free accountRatings are relative: the forecasts of the latest complete daily run (2026-10-15) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.